中国全科医学 ›› 2018, Vol. 21 ›› Issue (13): 1585-1588.DOI: 10.3969/j.issn.1007-9572.2018.13.015

• 专题研究 • 上一篇    下一篇

血清胃泌素17及胃蛋白酶原联合14C呼气试验在健康体检人群胃癌筛查中的价值研究

王书彩1,朱希燕2,李琛琮1,刘庆利1,杜亚强1*   

  1. 1.050012河北省石家庄市,河北医科大学第四医院体检部
    2.050012河北省石家庄市,河北医科大学第四医院胸外五科
    *通信作者:杜亚强,副主任医师;E-mail:halixundong@126.com
  • 出版日期:2018-05-05 发布日期:2018-05-05
  • 基金资助:
    河北省医学科学研究重点课题计划(20150811)

Serum Gastrin-17 and Pepsinogen Measurement Combined with 14C-UBT for Gastric Cancer Screening in Physical Examination

  1. 1.Physical Examination Center,Fourth Hospital of Hebei Medical University,Shijiazhuang 050012,China
    2 No.5 Department of Chest Surgery,Fourth Hospital of Hebei Medical University,Shijiazhuang 050012,China
    *Corresponding author:DU Ya-qiang,Associate chief physician;E-mail:halixundong@126.com
  • Published:2018-05-05 Online:2018-05-05

摘要: 目的 评价联合胃泌素17、胃蛋白酶原、14C呼气试验在健康体检人群中胃癌筛查的效果,为健康体检项目的制定提供理论依据。方法 选取2016年7—10月河北医科大学第四医院参与胃癌筛查项目的40岁及以上职工1 186例为研究对象,检测胃泌素17、胃蛋白酶原水平,并行14C呼气试验及无痛胃镜检查。结果 胃泌素17、胃蛋白酶原、14C呼气试验及联合筛查的阳性率分别为46.5%(219/471)、42.0%(198/471)、46.8%(206/440)、63.7%(242/380),其中联合筛查的阳性率高于胃泌素17、胃蛋白酶原、14C呼气试验(P<0.008 3)。共130例受试者参与无痛胃镜检查,检出萎缩性胃炎、胃溃疡、胃息肉、癌前病变分别有5、30、29、4例。联合筛查的胃溃疡、胃息肉阳性检出率高于胃泌素17、胃蛋白酶原、14C呼气试验,差异有统计学意义(P<0.008 3)。各筛查项目萎缩性胃炎、胃溃疡、胃息肉、癌前病变的阳性预测值比较,差异无统计学意义(P>0.05)。结论 联合胃泌素17、胃蛋白酶原、14C呼气试验能提高胃黏膜病变的阳性检出率,可作为胃癌高危人群的筛查项目。

关键词: 胃癌, 胃泌素类, 胃蛋白酶原类, 幽门螺杆菌, 筛查, 健康体检

Abstract: Objective To evaluate the effect of a combination test of gastrin-17(GAS-17) and pepsinogen measurement and 14C-UBT for gastric cancer screening in physical examination,providing a theoretical basis for the enaction of physical examination items.Methods The enrolled 1 186 participants were employees aged 40 or over from Fourth Hospital of Hebei Medical University.They underwent a physical examination from July to October,2017.The number of participants undergoing GAS-17 measurement,pepsinogen measurement,14C-UBT,combination test(GAS-17 and pepsinogen measurement combined with 14C-UBT) and painless gastroscopy for gastric cancer screening was 471,471,440,380,130,respectively.Results The overall positive prevalence detected by GAS-17 measurement,pepsinogen measurement,14C-UBT,combination test was 46.5%(219 cases),42.0%(198 cases),46.8%(206 cases),63.7%(242 cases),respectively,demonstrating that the combination test had higher positive rate than the other 3 methods(P<0.008 3).Moreover,the prevalence of gastric ulcer or gastric polyps detected by combination test was still higher compared with the other 3 methods(P<0.008 3).However,these 4 methods showed similar positive predictive value for atrophic gastritis,gastric ulcer,gastric polyps or gastric precancerous lesions(P>0.05).By painless gastrosopy,5 were found with atrophic gastritis,30 with gastric ulcer,29 with gastric polyps,and 4 with gastric precancerous lesions.Conclusion The combination test demonstrated higher detection rate of gastric diseases than each of its components alone,so it can be used as a screening item for high risk population for gastric cancer.

Key words: Gastric cancer, Gastrins, Pepsinogens, Helicobacter pylori, Screening, Physical examination